Hadassah

Study by Renowned Hadassah Neuropsychiatrist Featured in The Lancet

Thursday, Sep 7 2017

The work of Dr. Shahar Arzy, head of the Hadassah Medical Organization’s Neuropsychiatry Clinic and the Hadassah-Hebrew University Computational Neuropsychiatry Laboratory, is featured in the September 4, 2017 issue of The Lancet Psychiatry.

Dr. Arzy’s study, in collaboration with colleagues in Berlin, Germany, involved 43 patients with a particular form of severe brain inflammation. Using functional magnetic resonance imaging (MRI), the research team was able to witness changes in the connections within the patients’ brain networks.

Individuals who suffer from this particular form of brain inflammation called “anti-NMDA receptor encephalitis,” exhibit severe neuropsychiatric symptoms, including psychosis, memory deficits, and movement disorders. How the specific dysfunction leads to these clinical symptoms, however, is not understood. Do the symptoms arise from an impairment in specific brain regions? Do they arise from the interactions between these impaired regions?  The answers remain elusive.

In this study, Dr. Arzy’s research team observed 43 age and sex-matched healthy individuals, along with the 43 who had encephalitis. Although structural MRI proved normal in 31 (72 percent) of the 43 patients, the researchers report that they observed “widespread alterations of functional connectivity” and that these alterations correlated with what they saw clinically. The authors explain that “memory impairment correlated with hippocampal and medial-temporal-lobe network connectivity, whereas schizophrenia-like symptoms were associated with functional connectivity changes in frontoparietal networks.”

As the authors summarize: “This study reveals a characteristic pattern of whole-brain functional connectivity alterations in anti-NMDAR encephalitis that is well suited to explain the major clinical symptoms of the disorder.”  They also note that their findings could be similarly relevant for other neuropsychiatric disorders, such as schizophrenia.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, Oct 15 2018

Hadassah Dedicates Irma and Paul Milstein Heart Center at Hadassah Hospital Ein Kerem

Hadassah unveiled the Irma and Paul Milstein Heart Center at Hadassah Hospital Ein Kerem on Friday, October 12th in Jerusalem, announced Ellen Hershkin, National President, Hadassah, the Women’s Zionist Organization of America, Inc.

READ MORE ›
alt_text

Monday, Oct 15 2018

Hadassah Dedicates Irma and Paul Milstein Heart Center at Hadassah Hospital Ein Kerem News Release

Hadassah unveiled the Irma and Paul Milstein Heart Center at Hadassah Hospital Ein Kerem on Friday, October 12th in Jerusalem, announced Ellen Hershkin, National President, Hadassah, the Women’s Zionist Organization of America, Inc.

READ MORE ›
alt_text

Friday, Oct 12 2018

New Zealand Scholarship Winner Comes to Hadassah Hospital

Describing it as a “life-changing experience,” Dinithi Seneviratne, a New Zealand health care professional, recently spent several weeks as an observer in the Pediatric Emergency Department at Hadassah Hospital in Ein Kerem, Jerusalem.

READ MORE ›
alt_text

Thursday, Oct 4 2018

Hadassah Receives $4.75M Grant from Helmsley Charitable Trust to Expand New Pediatric Bone Marrow Transplant (BMT) Unit

The Helmsley Charitable Trust has awarded a $4.75M grant to the Hadassah Medical Organization (HMO) in Israel to expand its Pediatric Bone Marrow Transplant (BMT) Unit, announced Ellen Hershkin, National President, Hadassah, The Women’s Zionist Organization of America, Inc. (HWZOA).

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More